Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2017

View Archived Issues

Genocea Biosciences announces topline data from phase IIb study of GEN-003

ALT-803 induces NK- and T-cell activation in SIV-infected macaques

GlaxoSmithKline submits sNDA to the FDA for Arnuity Ellipta in children with asthma

Serum 3-nitrotyrosine is a potential prediagnosis biomarker of postsurgery sepsis

Topline data reported from Novavax's phase II study of RSV F vaccine

Phase III study of Keytruda in HNSCC misses primary endpoint

Frontier Biotechnologies enters agreement with Rockefeller University

Aptevo and Alligator Bioscience to codevelop cancer immunotherapy

Ono Pharmaceutical presents promising in vitro and preclinical data for ONO-5450598

Flex Pharma's FLX-787 wins FDA fast track status for muscle cramps in ALS patients

Investigators in China patent MAPK 1 inhibitors

Asthma compounds identified at Sichuan Haisco Pharmaceutical

Karyopharm Therapeutics presents exportin-1 antagonists

UCB files for U.S. and E.U. approvals for Cimzia in moderate to severe chronic plaque psoriasis

Compounds for cancer discovered at Karyopharm Therapeutics

Axsome Therapeutics reports positive topline results from phase I study of AXS-06

Sernova provides update on regenerative medicine therapy for hemophilia A

FDA grants fast track designation to caplacizumab for acquired thrombotic thrombocytopenic purpura

Onconova Therapeutics enters agreements to advance rigosertib in pediatric RASopathies

Tetraphase reports topline results from IGNITE4 trial of eravacycline in cIAI

AntriaBio doses first patient in phase I study of AB-101

Santen initiates phase IIa study of DE-122 for wet AMD

The Medicines Co. provides update on TANGO-2 study of meropenem/vaborbactam

Phase III data for glecaprevir/pibrentasvir combination in HIV-1/HCV coinfected patients presented

Eisai seeks approval of lenvatinib for HCC in U.S. and E.U.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...